Stay updated on Biomarker Response to Pembrolizumab in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Biomarker Response to Pembrolizumab in NSCLC Clinical Trial page.
Latest updates to the Biomarker Response to Pembrolizumab in NSCLC Clinical Trial page
- Check2 days agoChange DetectedThe website has updated the 'type of intervention' feature from version 2.13.3 to 2.14.0, indicating a significant change in this functionality.SummaryDifference0.2%
- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedThe website has been updated from version 2.13.2 to 2.13.3.SummaryDifference0.1%
- Check38 days agoChange DetectedThe website has updated the contact details section for the study, clarifying that it now provides information for individuals who can answer questions about joining the study and includes a reference to the Contacts and Locations section.SummaryDifference2%
- Check53 days agoChange DetectedThe website has added a 'Show less' option, while several detailed data fields and download options related to clinical study information have been removed.SummaryDifference3%
- Check60 days agoChange DetectedSeveral key health-related links have been removed, including those related to genetics, lung cancer, and clinical trials, which may impact access to important medical information.SummaryDifference0.4%
- Check67 days agoChange DetectedThe website has added several new resources related to lung cancer, including links to MedlinePlus and Dailymed, as well as updates to clinical trial documentation, while the previous revision (v2.12.1) has been removed.SummaryDifference4%
Stay in the know with updates to Biomarker Response to Pembrolizumab in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Biomarker Response to Pembrolizumab in NSCLC Clinical Trial page.